Vaccination for children aged 15-18 years to begin from Monday | 10 points
3 years, 2 months ago

Vaccination for children aged 15-18 years to begin from Monday | 10 points

India TV News  

Vaccination for children aged 15-18 years to begin from Monday | 10 points Bharat Biotech International Limited has announced that BBV152, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. Highlights Vaccination drive for children aged 15-18 years will begin from January 3 Bharat Biotech's COVAXIN is the only approved vaccine for children in India as of now Covaxin has proven to be safe, well-tolerated, and immunogenic in paediatric subjects Vaccination of children in the 15-18 age group against COVID-19 will begin from Monday, January 3, registration for which already began on January 1 on the COWIN portal. The vaccination against COVID-19 of 36 lakh school children in the 15-18 age group in Madhya Pradesh will begin from Monday, with plans afoot to administer doses to 12 lakh beneficiaries in this segment on the first day, a senior health official said. There are 36 lakh registered schoolchildren in the 15-18 age group in the state and the vaccination drive for them will start from January 3, Madhya Pradesh Immunisation Officer Dr Santosh Shukla said.

Children Vaccination Age Minister Covid Group Lakh Vaccine Bharat Biotech Covaxin Paediatric Subjects  begin  minister  age  covid19  group  lakh  1518  15  aged  points  children  vaccination  vaccine

History of this topic

National Vaccination Day 2025: Date, history, significance
1 week, 3 days ago

National Vaccination Day 2025: Date, history, significance

India Today  

National Vaccination Day is a testament to India's unwavering dedication to public health through immunisation. As we observe National Vaccination Day 2025, let us reaffirm our commitment to vaccination, recognising it as a cornerstone of public health and a vital tool in safeguarding future generations. HISTORY OF NATIONAL VACCINATION DAY The inception of National Vaccination Day dates back to March …

Adult immunisation can provide protection from multiple diseases. Why is it not a priority in India?
2 weeks ago

Adult immunisation can provide protection from multiple diseases. Why is it not a priority in India?

The Hindu  

When was the last time you thought about getting vaccinated as an adult? “Doctors are themselves very poorly informed about adult vaccination, as adult immunisation doesn’t fall under any particular medical specialisation, making it easy to overlook,” says V. Ramasubramanian, infectious diseases specialist, Apollo Hospitals, Chennai. What adult immunisations can protect from Shingles : Shingles vaccine Influenza : Influenza vaccine …

Cancer Vaccine for women set to launch in India within 5-6 months; Girls aged 9-16 to be eligible for inoculation
1 month, 1 week ago

Cancer Vaccine for women set to launch in India within 5-6 months; Girls aged 9-16 to be eligible for inoculation

Live Mint  

A vaccine to fight cancers affecting women will be available in five to six months, and those in the age group of nine to 16 years will be eligible for inoculation, Union Minister Prataprao Jadhav said on Tuesday. Addressing a press conference in Chhatrapati Sambhajinagar, the Union Minister of State for Health, Family Welfare and Ayush said that research on …

Global childhood vax coverage stalled in 2023, 2.7 million kids unprotected, says UN
8 months, 1 week ago

Global childhood vax coverage stalled in 2023, 2.7 million kids unprotected, says UN

New Indian Express  

NEW DELHI: Global childhood vaccination coverage stalled in 2023, leaving an estimated 2.7 million children more un- and under-vaccinated compared to pre-pandemic levels in 2019, according to the UN on Monday. Warning of an alarming coverage gap that has led to an outbreak of diseases like malaria, the latest World Health Organisation and UNICEF estimates of national immunisation coverage said …

Govt to soon launch CoWIN-like platform for its vaccination drive
8 months, 1 week ago

Govt to soon launch CoWIN-like platform for its vaccination drive

Hindustan Times  

India will soon deploy a centralised online platform and database called UWIN on the government’s immunisation programme for children and pregnant women that has been developed by the health ministry on the lines of the CoWin platform that was successfully used for vaccination during the Covid-19 pandemic, according to people familiar with the matter. U-WIN will capture each vaccination event …

Special vax drive in Rayagada after diphtheria outbreak
9 months, 1 week ago

Special vax drive in Rayagada after diphtheria outbreak

New Indian Express  

BHUBANESWAR: The Odisha government has decided to launch a special drive for diphtheria vaccination in Rayagada district from Wednesday following an outbreak in Kashipur area that has claimed the lives of five children. While in and out migration from Mahushpadar village where the children fell to the bacterial infection has been restricted, containment measures will continue to minimise spread of …

Why COVID vaccine safety needs scrutiny | Explained
10 months ago

Why COVID vaccine safety needs scrutiny | Explained

The Hindu  

The story so far: The Indian Council for Medical Research issued a letter to the researchers of Banaras Hindu University last week, countering their study on the side effects of India’s indigenous vaccine for COVID — Covaxin. The one-year observational, follow-up study titled ‘Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: Findings from a one-year prospective …

BHU study: Over 30 per cent of Covaxin recipients report adverse events
10 months, 1 week ago

BHU study: Over 30 per cent of Covaxin recipients report adverse events

India TV News  

A recent study conducted by researchers at Banaras Hindu University revealed that over 30% of individuals who received Bharat Biotech's Covaxin reported adverse events. The one-year follow-up study, encompassing 926 participants, shed light on the long-term safety of the BBV152 vaccine, with serious adverse events of special interest such as stroke and Guillain-Barre syndrome reported in one per cent of …

Over 30% Covaxin takers suffered from health issues after one year, claims BHU study
10 months, 1 week ago

Over 30% Covaxin takers suffered from health issues after one year, claims BHU study

New Indian Express  

NEW DELHI: Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study conducted by a team of researchers at Banaras Hindu University. Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at …

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
10 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times  

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

A vaccine that prevents six cancers
1 year ago

A vaccine that prevents six cancers

The Hindu  

January was observed as Cervical Cancer Awareness Month. As the fourth most common cancer among women worldwide, cervical cancer claims the lives of more than 3,00,000 women every year, or one life every two minutes. The intervention targets are: 90% of girls must be fully vaccinated with the HPV vaccine by the age of 15; 70% of women must be …

Serum’s HPV vaccine non-inferior to Gardasil: study
1 year, 1 month ago

Serum’s HPV vaccine non-inferior to Gardasil: study

The Hindu  

February 10, 2024 09:10 pm | Updated 09:10 pm IST A phase-2/3 trial of Serum Institute of India’s human papillomavirus vaccine Cervavac conducted at 12 tertiary care hospitals across India in girls and boys aged 9-14 years has found the vaccine to be safe and non-inferior to a comparator vaccine Gardasil manufactured by Merck. While Serum’s Cervavac vaccine was administered …

Health Talk | Why vaccinating girls between 9 to 14 years against cervical cancer is vital
1 year, 1 month ago

Health Talk | Why vaccinating girls between 9 to 14 years against cervical cancer is vital

Hindustan Times  

Union finance minister Nirmala Sitharaman announced during her Budget speech on Thursday that the Centre planned to encourage cervical cancer vaccination for girls in the age group of 9 to 14 years. Experts said that vaccinating young girls is key to eliminating cervical cancer — one of the leading cancers in Indian women, and vaccine-preventable. “The results of the effectiveness …

Health Ministry yet to take a call on beginning HPV vaccination campaign for adolescent girls
1 year, 2 months ago

Health Ministry yet to take a call on beginning HPV vaccination campaign for adolescent girls

The Hindu  

The Health Ministry maintained on Saturday that it is yet to take a decision on starting a vaccination campaign against the human papillomavirus, despite reports that it is set to offer the vaccine from the second quarter of this year. The Ministry had earlier said that in June 2022, after evaluating the fresh evidence on the cervical cancer burden and …

Covid variant JN.1 spreading fast; preventive tips for children
1 year, 2 months ago

Covid variant JN.1 spreading fast; preventive tips for children

Hindustan Times  

Amid the rapid spread of Covid-19 variant JN.1 globally, over 150 cases of the new strain have been detected in India across several cities. While it's not clear whether the existing vaccinations will provide full protection from this new sub-variant, vulnerable populations including children must follow preventive measures to prevent spread. As the world grapples with the emergence of the …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year, 2 months ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year, 3 months ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 4 months ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

Tamil Nadu’s overall immunisation coverage has crossed 95%, says DPH
1 year, 4 months ago

Tamil Nadu’s overall immunisation coverage has crossed 95%, says DPH

The Hindu  

Tamil Nadu’s overall immunisation coverage has crossed 95%. Every year, 9.15 lakh children and 10 lakh pregnant women are covered under the Universal Immunisation Programme, and 3.2 crore vaccines worth nearly ₹10 crore are provided in the State, according to the Directorate of Public Health and Preventive Medicine. Vaccines were available for free in all government health facilities to prevent …

Hesitating to vaccinate your child? Parents should know these myths and facts about vaccinations in children
1 year, 7 months ago

Hesitating to vaccinate your child? Parents should know these myths and facts about vaccinations in children

Hindustan Times  

Despite sustained and dedicated efforts by Government of India, the immunisation coverage in India remains pretty low and data shows that only about 65% of eligible children receive all the recommended vaccines in their 1st year of life. Yet when the vaccines came and were granted emergency use authorisation, there were apprehensions and wary refusals from several corners of the …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 9 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report
1 year, 11 months ago

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report

The Hindu  

Only China, India, and Mexico, that is three out of the 55 countries studied for popular perception of the importance of vaccines for children, showed improvement as per data collected by The Vaccine Confidence Project and published by UNICEF on April 20. UNICEF India today released the agency’s global flagship report ‘The State of the World’s Children 2023: For Every …

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
1 year, 11 months ago

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Hindustan Times  

Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute of India on March 27, they said. …

NTAGI panel takes up inclusion of Covid jab COVOVAX on CoWIN portal
2 years, 1 month ago

NTAGI panel takes up inclusion of Covid jab COVOVAX on CoWIN portal

India TV News  

The National Technical Advisory Group on Immunisation met on Saturday to discuss the incusion of Covovax vaccine for adults on the CoWin portal, official sources said. According to an official source, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had written to the Health Ministry last month seeking inclusion of Covovax on the …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
2 years, 1 month ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1
2 years, 1 month ago

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1

News 18  

Over 7,000 doses of the world’s first intranasal Covid-19 vaccine, Bharat Biotech’s iNCOVACC, have been checked and released by the country’s apex vaccine testing laboratory, News18.com has learnt. BBV154, a novel adenovirus vectored intranasal vaccine for Covid-19, was sent to CDL in the first week of January in around six batches containing 15,000 doses. In polio, the dropper drops the …

Nasal vaccine at govt centres in Delhi from Feb 15
2 years, 1 month ago

Nasal vaccine at govt centres in Delhi from Feb 15

Hindustan Times  

India’s first nasal vaccine for Covid-19, iNCOVACC, which was formally launched on Thursday, is likely to be made available at government centres in the national capital by mid-February, senior officials of the Delhi government said on Friday. Union health minister Mansukh Mandaviya and science and technology minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
2 years, 2 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

What is nasal vaccine - iNCOVACC? All you need to know
2 years, 2 months ago

What is nasal vaccine - iNCOVACC? All you need to know

India TV News  

Covid19 nasal vaccine : Union Health Minister Mansukh Mandaviya on Friday launched Bharat Biotech's first India-made nasal Vaccine, iNCOVACC, as a booster shot for Covid19. According to Bharat Biotech, the nasal vaccine is likely to prevent infection, thus, preventing the transmission of the virus. The event saw the Union Minister of State Science & Technology; Minister of State Earth Sciences; …

Centre rolls out first nasal Covid vaccine as booster
2 years, 2 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
2 years, 2 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times  

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
2 years, 2 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint  

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
2 years, 2 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26
2 years, 2 months ago

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26

Hindustan Times  

Bhopal: Bharat Biotech’s nasal Covid-19 vaccine iNCOVACC is expected to be launched on January 26, executive chairman Krishna Ella said at an event on Saturday. “Our nasal vaccine will be officially launched on January 26 on Republic Day,” Ella told students at the Maulana Azad National Institute of Technology in Bhopal, where the India International Science Festival, 2022, is being …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
2 years, 2 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
2 years, 2 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years, 2 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
2 years, 2 months ago

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals

Live Mint  

NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine--iNCOVACC --will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. Clinical trials were …

Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster
2 years, 2 months ago

Rs 800 at Pvt Hosps, Rs 325 at Govt Centres: India's 1st Needle-free Nasal Vax, Now Available as Booster

News 18  

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC is now available on CoWin application for Rs 800, while Rs 325 has been fixed for purchase in government facilities. Provided that private hospitals are permitted to charge up to Rs 150 as an administrative charge for every dose of the Covid-19 vaccine, one dose of this vaccine developed on a …

Nasal vaccines to roll out in private hospitals soon
2 years, 3 months ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know
2 years, 3 months ago

Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening. What is the new nasal vaccine developed by Bharat Biotech? This vaccine candidate was evaluated in phase I, II and III clinical trials with …

Bharat Biotech’s nasal vaccine to be available as booster dose
2 years, 3 months ago

Bharat Biotech’s nasal vaccine to be available as booster dose

The Hindu  

With the threat of COVID-19 resurfacing and India ramping up preventive health surveillance measures, Health Minister Mansukh Mandaviya said on Friday that a vaccine, which could be administered as nasal drops, would henceforth be available for public use. “We have made available a nasal vaccine, developed by Bharat Biotech, that can be used as a precaution dose. A spokesperson for …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years, 3 months ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose
2 years, 3 months ago

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose

India TV News  

Bharat Biotech's needle-free intranasal Covid vaccine approved as booster dose Bharat Biotech nasal vaccine: According to reports, two drops of the vaccine can be treated as a dose. Bharat Biotech's needle-free intranasal Covid vaccine has been approved by the Centre as booster dose for those aged above 18, official sources said. Meanwhile, the Indian Medical Association has advised people to …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years, 3 months ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

Covid Vaccine: Is it time to vaccinate children under 12-years of age? Dr Randeep Guleria answers
2 years, 3 months ago

Covid Vaccine: Is it time to vaccinate children under 12-years of age? Dr Randeep Guleria answers

India TV News  

Covid Vaccine: Is it time to vaccinate children under 12-years of age? Dr Randeep Guleria answers Ex-director of the All India Institute of Medical Sciences New Delhi, Dr. Randeep Guleria throws some light on what needs to be our action plan as concerns over coronavirus again take the spotlight. Speaking on the same to India TV, ex-director of the All …

India to soon launch HPV vaccines for Cervical Cancer; know about its doses and diagnosis
2 years, 3 months ago

India to soon launch HPV vaccines for Cervical Cancer; know about its doses and diagnosis

India TV News  

Cervical cancer can be treated with the HPV vaccine and India is soon to take steps in this area. Dr. NK Arora, head of the National Technical Advisory Group on Immunization, said that cervical cancer can be treated with the HPV vaccine. Teens and young adults through age 26 years who didn’t start or finish the HPV vaccine series also …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years, 3 months ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 4 months ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 4 months ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Discover Related